Literature DB >> 2502956

[Prevalence of patent foramen ovale in young patients with ischemic cerebral complications].

P Lechat1, G Lascault, J L Mas, P Loron, K Klimczac, M Guggiari, G Drobinski, J B Fraysse, D Thomas, Y Grosgogeat.   

Abstract

We compared the prevalence of patent foramen ovale (PFO), detected by two-dimensional contrast echocardiography, in a group of 60 adults aged under 55 who had experienced a cerebral ischaemic accident and had normal standard examination of the heart, and in a control group of 100 patients. The prevalence of PFO was significantly higher in neurological patients (40 p. 100) than in controls (10 p. 100; p less than 0.001). Within the neurological group, the prevalence of PFO determined blindly, i.e. without any knowledge of the aetiological diagnosis, increased with the uncertainty of diagnosis: 21 p. 100 when a cause could be determined (n = 19), 40 p. 100 when a facilitating factor of cerebral accident, such as mitral valve prolapse, migraine or consumption of oral contraceptives, could be identified (n = 15), and 54 p. 100 when neither cause nor facilitating factor could be found (n = 26; p less than 0.10). In view of the very high prevalence of clinically silent venous thrombosis, these results suggest that paradoxical embolism through a PFO might be responsible for cerebral ischaemic accidents more frequently than is generally believed.

Entities:  

Mesh:

Year:  1989        PMID: 2502956

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  4 in total

1.  Focal cerebral ischemia and patent cardiac foramen ovale.

Authors:  C Gandolfo; D Papagna; M A Rossi; E Favale; C Loeb; U Martini; E Moretti
Journal:  Ital J Neurol Sci       Date:  1994-04

Review 2.  Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.

Authors:  Brunilda Alushi; Alexander Lauten; Salvatore Cassese; Roisin Colleran; Stefanie Schüpke; Himanshu Rai; Heribert Schunkert; Bernhard Meier; Ulf Landmesser; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2018-04-11       Impact factor: 5.460

3.  Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design.

Authors:  Ahmed A Khattab; Stephan Windecker; Peter Jüni; David Hildick-Smith; Dariusz Dudek; Henning R Andersen; Reda Ibrahim; Gerhard Schuler; Antony S Walton; Andreas Wahl; Heinrich P Mattle; Bernhard Meier
Journal:  Trials       Date:  2011-02-28       Impact factor: 2.279

4.  Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials.

Authors:  Irbaz Bin Riaz; Abhijeet Dhoble; Ahmad Mizyed; Chiu-Hsieh Hsu; Muhammad Husnain; Justin Z Lee; Kapildeo Lotun; Kwan S Lee
Journal:  BMC Cardiovasc Disord       Date:  2013-12-11       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.